Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 4

Status

Recruiting 4Completed 4Unknown 3Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Carcinoma, Non-Small-Cell Lung 173Leukemia, Myeloid, Acute 153Neoplasm Metastasis 145Neoplasms 142Breast Neoplasms 142Colorectal Neoplasms 135Recurrence 105Ovarian Neoplasms 100Pancreatic Neoplasms 81Multiple Myeloma 81Lung Neoplasms 81Advanced Solid Tumor 80Advanced Solid Tumors 74Prostatic Neoplasms 73Stomach Neoplasms 72Squamous Cell Carcinoma of Head and Neck 72Carcinoma, Hepatocellular 67Glioblastoma 65Melanoma 64Lymphoma, Non-Hodgkin 63Triple Negative Breast Neoplasms 57Myelodysplastic Syndromes 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Lymphoma, B-Cell 53Endometrial Neoplasms 52Glioma 51Lymphoma 49Brain Neoplasms 46Hematologic Neoplasms 44Carcinoma, Renal Cell 44

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Locally Advanced or Metastatic Solid Tumors × Clear all
NCT06307795 2026-04-17

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Avistone Biotechnology Co., Ltd.

Phase 1 Recruiting
63 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06349811 2025-06-15

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 1 Recruiting
30 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05205109 2025-06-09

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

Antengene Corporation

Phase 1 Recruiting
98 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06246071 2024-02-07

ASOTIAPWST

TYK Medicines, Inc

Phase 1 Recruiting
156 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡